Interaction between CD226 and its ligands - CD155 and CD112—seems to be crucial for cytotoxic activity of NK cells in myeloid leukemias, as it promotes NK cell adhesion to AML cells and enables leukemic cell killing. This evidence concerns the gene PVR and acute myeloid leukemia.